Brokerages expect Hill-Rom Holdings, Inc. (NYSE:HRC) to post earnings of $1.51 per share for the current quarter, Zacks reports. Four analysts have provided estimates for Hill-Rom’s earnings. The highest EPS estimate is $1.52 and the lowest is $1.50. Hill-Rom reported earnings per share of $1.32 in the same quarter last year, which indicates a positive year over year growth rate of 14.4%. The firm is scheduled to issue its next quarterly earnings results on Friday, November 2nd.
On average, analysts expect that Hill-Rom will report full year earnings of $4.64 per share for the current financial year, with EPS estimates ranging from $4.63 to $4.65. For the next fiscal year, analysts forecast that the business will post earnings of $5.11 per share, with EPS estimates ranging from $5.06 to $5.18. Zacks’ EPS calculations are an average based on a survey of sell-side research analysts that follow Hill-Rom.
Hill-Rom (NYSE:HRC) last posted its quarterly earnings results on Friday, July 27th. The medical technology company reported $1.15 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.13 by $0.02. The business had revenue of $708.60 million for the quarter, compared to analyst estimates of $707.50 million. Hill-Rom had a net margin of 8.19% and a return on equity of 20.54%. The firm’s revenue for the quarter was up 2.8% on a year-over-year basis. During the same quarter last year, the business posted $0.91 EPS.
A number of brokerages have weighed in on HRC. ValuEngine upgraded shares of Hill-Rom from a “hold” rating to a “buy” rating in a research report on Tuesday, July 31st. Northcoast Research restated a “buy” rating and issued a $104.00 target price on shares of Hill-Rom in a research report on Tuesday, July 31st. Zacks Investment Research lowered shares of Hill-Rom from a “buy” rating to a “hold” rating in a research report on Wednesday, August 1st. Raymond James raised their target price on shares of Hill-Rom from $97.00 to $100.00 and gave the company an “outperform” rating in a research report on Monday, July 30th. Finally, KeyCorp raised their target price on shares of Hill-Rom from $97.00 to $115.00 and gave the company an “overweight” rating in a research report on Tuesday, July 17th. Four investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. The stock has an average rating of “Buy” and a consensus price target of $100.00.
Shares of NYSE HRC traded down $1.60 during trading hours on Wednesday, hitting $94.27. 9,423 shares of the stock were exchanged, compared to its average volume of 322,268. The company has a current ratio of 1.58, a quick ratio of 1.18 and a debt-to-equity ratio of 1.24. The firm has a market capitalization of $6.34 billion, a price-to-earnings ratio of 24.50, a P/E/G ratio of 1.48 and a beta of 0.89. Hill-Rom has a 1-year low of $71.91 and a 1-year high of $98.96.
The business also recently announced a quarterly dividend, which will be paid on Friday, September 28th. Shareholders of record on Friday, September 21st will be given a $0.20 dividend. The ex-dividend date of this dividend is Thursday, September 20th. This represents a $0.80 dividend on an annualized basis and a yield of 0.85%. Hill-Rom’s dividend payout ratio is currently 20.73%.
Institutional investors have recently modified their holdings of the business. Advisors Asset Management Inc. raised its stake in shares of Hill-Rom by 557.8% during the second quarter. Advisors Asset Management Inc. now owns 6,749 shares of the medical technology company’s stock valued at $589,000 after acquiring an additional 5,723 shares during the last quarter. WINTON GROUP Ltd raised its stake in shares of Hill-Rom by 488.4% during the second quarter. WINTON GROUP Ltd now owns 108,252 shares of the medical technology company’s stock valued at $9,455,000 after acquiring an additional 89,855 shares during the last quarter. Verition Fund Management LLC bought a new position in shares of Hill-Rom during the second quarter valued at $1,081,000. California Public Employees Retirement System raised its stake in shares of Hill-Rom by 3.2% during the second quarter. California Public Employees Retirement System now owns 177,972 shares of the medical technology company’s stock valued at $15,544,000 after acquiring an additional 5,501 shares during the last quarter. Finally, Putnam Investments LLC bought a new position in shares of Hill-Rom during the second quarter valued at $3,201,000. Hedge funds and other institutional investors own 84.84% of the company’s stock.
Hill-Rom Company Profile
Hill-Rom Holdings, Inc operates as a medical technology company worldwide. It provides medical surgical beds, intensive care unit beds, bariatric patient beds, lifts and other devices, non-invasive therapeutic products and surfaces, and communications technologies and software solutions; and medical equipment management services, as well as sells equipment service contracts for its capital equipment.
Further Reading: Stock Symbols Definition, Examples, Lookup
Get a free copy of the Zacks research report on Hill-Rom (HRC)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Hill-Rom Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hill-Rom and related companies with MarketBeat.com's FREE daily email newsletter.